Value Line Funds · Q3 2026 · Quarterly letter
Stephen E. Grant reports that Value Line Small Cap Opportunities Fund returned -8.16% in Q3 2026 against -9.58% for its Morningstar category, helped by Ensign Group, Medpace and Merit Medical in Health Care and CACI International and ExlService in Industrials.
Stephen E. Grant reviews the third quarter of 2026 for the Value Line Small Cap Opportunities Fund. Small-cap growth stocks fell, and rising rates in September hit the less volatile companies the fund favours, yet the fund lost less than its Morningstar category. Stock selection in Health Care, Industrials, Information Technology and Materials helped, while AAON, RBC Bearings, SPX Technologies and Woodward detracted. The fund bought Materion and IDT and sold Exponent, SiteOne (the landscaping supplier), Badger Meter, MACOM and TopBuild.